BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 18851793)

  • 1. [Malignant transformation of ovarian endometriosis: a clinicopathologic analysis of 49 cases].
    Shen YM; Wu XL; Xu L; Huang Q; Yu N; Yao XY; Xie YP
    Ai Zheng; 2008 Oct; 27(10):1106-10. PubMed ID: 18851793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of ARID1A/BAF250a expression in ovarian endometriosis and clear cell carcinoma.
    Xiao W; Awadallah A; Xin W
    Int J Clin Exp Pathol; 2012; 5(7):642-50. PubMed ID: 22977660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The malignant potential of ovarian atypical endometriosis].
    Guo L; Liu T; Lang J
    Zhonghua Bing Li Xue Za Zhi; 2001 Jun; 30(3):169-72. PubMed ID: 11866970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical analysis of 25 cases of malignant transformation of endometriosis of the ovary].
    Qian J; Shi Y; Chen X
    Zhonghua Fu Chan Ke Za Zhi; 2000 Nov; 35(11):667-9. PubMed ID: 11218895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian cancer arising in endometrioid cysts: ultrasound findings.
    Testa AC; Timmerman D; Van Holsbeke C; Zannoni GF; Fransis S; Moerman P; Vellone V; Mascilini F; Licameli A; Ludovisi M; Di Legge A; Scambia G; Ferrandina G
    Ultrasound Obstet Gynecol; 2011 Jul; 38(1):99-106. PubMed ID: 21351179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal changes in magnetic resonance imaging of malignant and borderline tumors associated with ovarian endometriotic cyst comparing with endometriotic cysts without arising malignancy.
    Nishio N; Kido A; Kataoka M; Kuwahara R; Nakao K; Kurata Y; Matsumura N; Mandai M; Togashi K
    Eur J Radiol; 2018 Aug; 105():175-181. PubMed ID: 30017276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors that Differentiate between Endometriosis-associated Ovarian Cancer and Benign Ovarian Endometriosis with Mural Nodules.
    Tanase Y; Kawaguchi R; Takahama J; Kobayashi H
    Magn Reson Med Sci; 2018 Jul; 17(3):231-237. PubMed ID: 28824051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study on estrogen and progesterone receptors in endometriosis and adenomyosis].
    Peng Z; Liu S; He B; Xi M; Cao Z
    Hua Xi Yi Ke Da Xue Xue Bao; 1993 Sep; 24(3):290-2. PubMed ID: 8288201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sonography of ovarian masses: poor sensitivity of resistive index for identifying malignant lesions.
    Levine D; Feldstein VA; Babcook CJ; Filly RA
    AJR Am J Roentgenol; 1994 Jun; 162(6):1355-9. PubMed ID: 8191998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian carcinoma in patients with endometriosis: MR imaging findings.
    Tanaka YO; Yoshizako T; Nishida M; Yamaguchi M; Sugimura K; Itai Y
    AJR Am J Roentgenol; 2000 Nov; 175(5):1423-30. PubMed ID: 11044056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CDC42-positive macrophages may prevent malignant transformation of ovarian endometriosis.
    Canet B; Pons C; Espinosa I; Prat J
    Hum Pathol; 2012 May; 43(5):720-5. PubMed ID: 21944080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Histologic examination and immunohistochemical analysis of estrogen and progesterone receptors of eutopic and ectopic endometrium in patients with endometriosis].
    Gu L; Zhang L; Gu F
    Zhonghua Fu Chan Ke Za Zhi; 1996 Oct; 31(10):582-5. PubMed ID: 9275449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [bcl-2 and p53 protein expressions in the malignant transformation of ovarian endometriosis].
    Qian J; Shi Y
    Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):403-5. PubMed ID: 11810773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant transformation of ovarian endometriosis.
    Nishida M; Watanabe K; Sato N; Ichikawa Y
    Gynecol Obstet Invest; 2000; 50 Suppl 1():18-25. PubMed ID: 11093057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant Transformation of Pelvic Endometriosis: Case Series and Review of the Literature.
    Jaiman S; Pochiraju M; Gundabattula SR; Surampudi K; Narayana Rao DV; Kandikattu S
    Int J Surg Pathol; 2015 Sep; 23(6):465-71. PubMed ID: 25911569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transmembrane estrogen receptor GPR30 is more frequently expressed in malignant than benign ovarian endometriotic cysts and correlates with MMP-9 expression.
    Long L; Cao Y; Tang LD
    Int J Gynecol Cancer; 2012 May; 22(4):539-45. PubMed ID: 22495744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative immunohistochemical study of deep infiltrating endometriosis, lymph node endometriosis and atypical ovarian endometriosis including description of a perineural invasion.
    Lenz J; Chvatal R; Fiala L; Konecna P; Lenz D
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2021 Mar; 165(1):69-79. PubMed ID: 32158015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histomorphological and Functional Features of the Eutopic Endometrium in Patients with Ovarian Endometriosis After Surgery-a Clinical Study.
    Mikhaleva LM; Solomatina AA; Milovanov AP; Beeraka NM; Khovanskaya TN; Chabieva LB; Mikhalev SA; Gracheva NA; Chigray LV; Beylerli O; Patsap OI; Aliev G
    Reprod Sci; 2021 Aug; 28(8):2350-2358. PubMed ID: 33650096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of M2 macrophages expressing heme oxygenase-1 in malignant transformation of ovarian endometrioma.
    Yamada Y; Uchiyama T; Ito F; Kawahara N; Ogawa K; Obayashi C; Kobayashi H
    Pathol Res Pract; 2019 Apr; 215(4):639-643. PubMed ID: 30567635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinicopathological features of malignant ovarian neoplasms arising from ovarian endometriosis: a report of 26 cases].
    Qu Y; Wang L; Zhu H
    Zhonghua Fu Chan Ke Za Zhi; 2001 Aug; 36(8):470-2. PubMed ID: 11758181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.